Furthermore, OT1-CD8+ T cells showed a dramatic antitumor effect in vivo when ZEB1 was knocked down in tumor tissue, highlighting the key function of ZEB1 in regulating the sensitivity of PC to CAR T cell therapy (Figure 3, G and H). This evidence concerns the gene CD8A and neoplasm.